S&P 500   4,305.20
DOW   34,152.01
QQQ   332.28
3 Stocks Set to Lead the Nasdaq Bull Market
US Dollar Replaced By "Biden Bucks"? (Ad)
3 Blowout Earnings Reports That Could Mark Turning Points
Companies facing 1st tax on stock buybacks in Biden bill
Will CrowdStrike Extend Its Streak Of Topping Earnings Views?
US Dollar Replaced By "Biden Bucks"? (Ad)
Is Ford About To Crush Workhorse Group? 
Home Depot Results Point To Sluggish 2nd Half
Skyworks Solutions Is Worth A Look At These Prices 
The Day of Financial Reckoning Is Near (Ad)
S&P 500   4,305.20
DOW   34,152.01
QQQ   332.28
3 Stocks Set to Lead the Nasdaq Bull Market
US Dollar Replaced By "Biden Bucks"? (Ad)
3 Blowout Earnings Reports That Could Mark Turning Points
Companies facing 1st tax on stock buybacks in Biden bill
Will CrowdStrike Extend Its Streak Of Topping Earnings Views?
US Dollar Replaced By "Biden Bucks"? (Ad)
Is Ford About To Crush Workhorse Group? 
Home Depot Results Point To Sluggish 2nd Half
Skyworks Solutions Is Worth A Look At These Prices 
The Day of Financial Reckoning Is Near (Ad)
S&P 500   4,305.20
DOW   34,152.01
QQQ   332.28
3 Stocks Set to Lead the Nasdaq Bull Market
US Dollar Replaced By "Biden Bucks"? (Ad)
3 Blowout Earnings Reports That Could Mark Turning Points
Companies facing 1st tax on stock buybacks in Biden bill
Will CrowdStrike Extend Its Streak Of Topping Earnings Views?
US Dollar Replaced By "Biden Bucks"? (Ad)
Is Ford About To Crush Workhorse Group? 
Home Depot Results Point To Sluggish 2nd Half
Skyworks Solutions Is Worth A Look At These Prices 
The Day of Financial Reckoning Is Near (Ad)
S&P 500   4,305.20
DOW   34,152.01
QQQ   332.28
3 Stocks Set to Lead the Nasdaq Bull Market
US Dollar Replaced By "Biden Bucks"? (Ad)
3 Blowout Earnings Reports That Could Mark Turning Points
Companies facing 1st tax on stock buybacks in Biden bill
Will CrowdStrike Extend Its Streak Of Topping Earnings Views?
US Dollar Replaced By "Biden Bucks"? (Ad)
Is Ford About To Crush Workhorse Group? 
Home Depot Results Point To Sluggish 2nd Half
Skyworks Solutions Is Worth A Look At These Prices 
The Day of Financial Reckoning Is Near (Ad)
NYSE:CIM

Chimera Investment - CIM Stock Forecast, Price & News

$9.59
-0.06 (-0.62%)
(As of 08/16/2022 12:00 AM ET)
Add
Compare
Today's Range
$9.51
$9.64
50-Day Range
$7.78
$10.53
52-Week Range
$7.72
$16.85
Volume
1.05 million shs
Average Volume
2.25 million shs
Market Capitalization
$2.22 billion
P/E Ratio
N/A
Dividend Yield
13.68%
Price Target
$9.25

Chimera Investment MarketRank™ Forecast

Analyst Rating
Hold
1.50 Rating Score
Upside/​Downside
3.5% Downside
$9.25 Price Target
Short Interest
Healthy
4.38% of Shares Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
1.31mentions of Chimera Investment in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
-4.79%
From $1.46 to $1.39 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.56 out of 5 stars

Finance Sector

873rd out of 924 stocks

Real Estate Investment Trusts Industry

177th out of 197 stocks

CIM stock logo

About Chimera Investment (NYSE:CIM) Stock

Chimera Investment Corporation operates as a real estate investment trust (REIT) in the United States. The company, through its subsidiaries, invests in a portfolio of mortgage assets, including residential mortgage loans, agency and non-agency residential mortgage-backed securities, agency mortgage-backed securities secured by pools of residential, commercial mortgage loans, and other real estate related securities. It has elected to be taxed as a REIT. In addition, the company invests in investment, non-investment grade, and non-rated classes. The company was incorporated in 2007 and is based in New York, New York.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on CIM shares. Credit Suisse Group dropped their price objective on shares of Chimera Investment to $9.50 in a report on Friday, July 22nd. Barclays cut their price objective on Chimera Investment from $11.00 to $9.00 and set an "underweight" rating on the stock in a report on Monday, July 18th.

Chimera Investment Stock Performance

CIM traded down $0.06 on Tuesday, hitting $9.59. 1,051,735 shares of the company traded hands, compared to its average volume of 2,250,363. The stock has a market capitalization of $2.22 billion, a PE ratio of -14.75 and a beta of 1.05. The company has a quick ratio of 4.60, a current ratio of 4.60 and a debt-to-equity ratio of 3.67. The company has a 50 day moving average of $9.24 and a 200-day moving average of $10.67. Chimera Investment has a 12-month low of $7.72 and a 12-month high of $16.85.

Chimera Investment (NYSE:CIM - Get Rating) last posted its quarterly earnings results on Thursday, August 4th. The real estate investment trust reported $0.31 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.37 by ($0.06). Chimera Investment had a positive return on equity of 13.07% and a negative net margin of 8.93%. The firm had revenue of $116.89 million for the quarter, compared to analysts' expectations of $131.19 million. During the same period in the prior year, the company earned $0.54 earnings per share. The company's revenue for the quarter was down 32.1% on a year-over-year basis. Sell-side analysts anticipate that Chimera Investment will post 1.46 earnings per share for the current year.

Receive CIM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chimera Investment and its competitors with MarketBeat's FREE daily newsletter.

CIM Stock News Headlines

Chimera Investment Corp - Stock Ownership CIM
Preparing For A Stormy Market With High Yield
CIM_pc Technical Analysis
CIM_pa Historical Data
Chimera Investment Tops Q1 EPS by 1c
See More Headlines
Receive CIM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chimera Investment and its competitors with MarketBeat's FREE daily newsletter.

CIM Company Calendar

Ex-Dividend for 7/28 Dividend
6/29/2022
Dividend Payable
7/28/2022
Last Earnings
8/04/2022
Today
8/16/2022
Next Earnings (Estimated)
11/02/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Real estate investment trusts
Sub-Industry
Mortgage REITs
Sector
Finance
CUSIP
16934Q10
Employees
38
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$9.25
High Stock Price Forecast
$9.50
Low Stock Price Forecast
$9.00
Forecasted Upside/Downside
-3.5%
Consensus Rating
Hold
Rating Score (0-4)
1.50
Research Coverage
2 Analysts

Profitability

Net Income
$670.11 million
Pretax Margin
-8.85%

Debt

Sales & Book Value

Annual Sales
$937.55 million
Cash Flow
$2.45 per share
Book Value
$15.77 per share

Miscellaneous

Free Float
230,662,000
Market Cap
$2.22 billion
Optionable
Optionable
Beta
1.05

Key Executives

  • Mr. Mohit Marria (Age 44)
    CEO, Chief Investment Officer & Director
    Comp: $5.39M
  • Mr. Choudhary Yarlagadda (Age 60)
    Pres, COO & Director
    Comp: $4.94M
  • Mr. Subramaniam Viswanathan (Age 50)
    Chief Financial Officer
    Comp: $1.5M
  • Mr. Phillip John Kardis II (Age 61)
    Esq., Chief Legal Officer & Corp. Sec.
    Comp: $4.2M
  • Mr. Kelley Kortman (Age 51)
    Chief Accounting Officer
  • Ms. Emily Mohr
    Investor Relations Officer
  • Victor Falvo
    Head of Capital Markets
  • Mr. Dan Thakkar
    Chief Risk Officer













CIM Stock - Frequently Asked Questions

Should I buy or sell Chimera Investment stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Chimera Investment in the last year. There are currently 1 sell rating and 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CIM shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CIM, but not buy additional shares or sell existing shares.
View CIM analyst ratings
or view top-rated stocks.

What is Chimera Investment's stock price forecast for 2022?

2 equities research analysts have issued twelve-month target prices for Chimera Investment's stock. Their CIM share price forecasts range from $9.00 to $9.50. On average, they predict the company's share price to reach $9.25 in the next year. This suggests that the stock has a possible downside of 3.5%.
View analysts price targets for CIM
or view top-rated stocks among Wall Street analysts.

How have CIM shares performed in 2022?

Chimera Investment's stock was trading at $15.08 at the beginning of 2022. Since then, CIM shares have decreased by 36.4% and is now trading at $9.59.
View the best growth stocks for 2022 here
.

Are investors shorting Chimera Investment?

Chimera Investment saw a decrease in short interest in July. As of July 31st, there was short interest totaling 10,140,000 shares, a decrease of 10.5% from the July 15th total of 11,330,000 shares. Based on an average daily trading volume, of 2,480,000 shares, the days-to-cover ratio is presently 4.1 days.
View Chimera Investment's Short Interest
.

When is Chimera Investment's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 2nd 2022.
View our CIM earnings forecast
.

How were Chimera Investment's earnings last quarter?

Chimera Investment Co. (NYSE:CIM) posted its earnings results on Thursday, August, 4th. The real estate investment trust reported $0.31 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.37 by $0.06. The real estate investment trust had revenue of $116.89 million for the quarter, compared to analyst estimates of $131.19 million. Chimera Investment had a negative net margin of 8.93% and a positive trailing twelve-month return on equity of 13.07%. The company's revenue for the quarter was down 32.1% on a year-over-year basis. During the same period last year, the firm posted $0.54 EPS.

How often does Chimera Investment pay dividends? What is the dividend yield for Chimera Investment?

Chimera Investment declared a quarterly dividend on Wednesday, May 4th. Investors of record on Thursday, June 30th will be paid a dividend of $0.33 per share on Thursday, July 28th. This represents a $1.32 dividend on an annualized basis and a yield of 13.76%. The ex-dividend date of this dividend is Wednesday, June 29th.
Read our dividend analysis for CIM
.

Is Chimera Investment a good dividend stock?

Chimera Investment (NYSE:CIM) pays an annual dividend of $1.32 per share and currently has a dividend yield of 13.68%. CIM has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for CIM.

What is Matthew Lambiase's approval rating as Chimera Investment's CEO?

3 employees have rated Chimera Investment Chief Executive Officer Matthew Lambiase on Glassdoor.com. Matthew Lambiase has an approval rating of 100% among the company's employees. This puts Matthew Lambiase in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Chimera Investment own?
What is Chimera Investment's stock symbol?

Chimera Investment trades on the New York Stock Exchange (NYSE) under the ticker symbol "CIM."

Who are Chimera Investment's major shareholders?

Chimera Investment's stock is owned by many different institutional and retail investors. Top institutional shareholders include Thornburg Investment Management Inc. (7.31%), Centiva Capital LP (3.55%), State Street Corp (2.30%), Leeward Investments LLC MA (1.25%), Northern Trust Corp (1.05%) and Capital Advisors Inc. OK (0.57%). Insiders that own company stock include Choudhary Yarlagadda, Kelley Kortman, Matthew Lambiase, Paul Donlin, Phillip John Kardis II and Robert S Colligan.
View institutional ownership trends
.

How do I buy shares of Chimera Investment?

Shares of CIM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Chimera Investment's stock price today?

One share of CIM stock can currently be purchased for approximately $9.59.

How much money does Chimera Investment make?

Chimera Investment (NYSE:CIM) has a market capitalization of $2.22 billion and generates $937.55 million in revenue each year. The real estate investment trust earns $670.11 million in net income (profit) each year or ($0.65) on an earnings per share basis.

How can I contact Chimera Investment?

Chimera Investment's mailing address is 520 MADISON AVENUE 32ND FLOOR, NEW YORK NY, 10022. The official website for the company is www.chimerareit.com. The real estate investment trust can be reached via phone at (212) 626-2300, via email at investor@chimerareit.com, or via fax at 212-696-9809.

This page (NYSE:CIM) was last updated on 8/17/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.